SpinaFX Medical today announced that it has appointed John Soloninka as chief operating officer. Soloninka brings more than 20 years of experience in health tech companies to SpinaFX, a minimally invasive image-guided therapy startup headquartered near Toronto, Canada. He was previously CEO and co-founder of a $28 million public/private venture debt fund, where he oversaw […]
Medtronic
Medtronic’s Hugo robotic-assisted surgical system wins regulatory nod in Europe
Medtronic (NYSE:MDT) announced that it received CE mark approval in Europe for its Hugo robotic-assisted surgery system. Fridley, Minnesota-based Medtronic’s CE mark covers urologic and gynecologic procedures, which make up approximately half of all robotic procedures performed today, according to a news release. Last month, the company said it had been expecting to receive such […]
BREAKING: Medtronic expands Class I recall of MiniMed 600 series insulin pumps
The FDA today announced that Medtronic (NYSE:MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps. Medtronic today notified customers by email and phone that the recall has been expanded to replace all MiniMed 600 series insulin pumps that contain the clear container ring. The Fridley, Minnesota-based company first warned of safety problems with the […]
Medtronic points to study showing that multi-hour AFib increases stroke risks
Medtronic (NYSE:MDT) announced today that a study using its continuous rhythm monitoring device showed AFib’s relationship with ischemic stroke. Fridley, Minnesota–based Medtronic’s data covers 466,635 patients included in the Optum unidentified electronic health record (EHR) and Medtronic CareLink databases. Findings were published online in JAMA Cardiology, according to a news release. Of the large population of […]
Former Medtronic and Zimmer-Biomet VP joins back pain startup as CEO
Jeff Cambra is the new CEO of SpinaFX Medical, the back pain therapy startup said on October 1. Cambra was previously a vice president at Zimmer Biomet (NYSE:ZBH), “leading product management for their $5 billion global reconstruction business,” SpinaFX said in a news release. He served in that role from November 2020 to June 2021, […]
Former Medtronic and Zimmer-Biomet VP joins back pain startup as CEO
Jeff Cambra is the new CEO of SpinaFX Medical, the back pain therapy startup said on Friday. Cambra was previously a vice president at Zimmer Biomet (NYSE:ZBH), “leading product management for their $5 billion global reconstruction business,” SpinaFX said in a news release. He served in that role from November 2020 to June 2021, according […]
Medtronic adds three new devices to minimally invasive spinal business
Medtronic (NYSE:MDT) this week announced that it has launched three new devices for its minimally invasive spinal technologies ecosystem. The Fridley, Minnesota-based company launched its Catalyft PL and PL40 for the Catalyft expandable interbody system. Medtronic designed it for anterior rim engagement with a beveled tip for ease of insertion, integration with StealthStation Navigation, simplified bone […]
Medtronic wins CE mark approval for radial artery access portfolio
Medtronic today said it has received CE mark approval for its radial artery access portfolio. The radial artery access devices include the Rist 079 radial access guide catheter and the Rist radial access selective catheter. Medtronic designed the Rist 079 guide catheter to access the neuro vasculature through the radial artery instead of through the […]
Medtronic CFO offers supply chain update as medical device industry concerns mount
Medtronic (NYSE:MDT) was among the participants in a White House semiconductor summit last week to address the continuing global shortage of electronic chips. Still, CFO Karen Parkhill says the world’s largest medical device manufacturer is not in the same dire straits as chip buyers in other industries. Medtronic’s supply chain is “holding up OK, but […]
Medtronic’s IP dispute against Axonics could resume in court after PTAB decisions
Medtronic (NYSE:MDT) and Axonics (NSDQ:AXNX) could see their patent dispute over neurostimulation technology resume in court. Yesterday, the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office affirmed an additional three patents in a long-term dispute between the companies over intellectual property for Medtronic’s Interstim sacral neuromodulation (SNM) system, completing the review process […]
Medtronic enrolls first patient in trial of growth modulation system for treating scoliosis
Medtronic (NYSE:MDT) announced today that it enrolled the first patient in a study for its Braive growth modulation system. Fridley, Minn.-based Medtronic also completed the first surgical procedure in the BRAIVE investigational device exemption (IDE) study evaluating the safety and effectiveness of the Braive growth modulation system for treating progressive adolescent idiopathic scoliosis. The first […]
